Désolé, cet article est seulement disponible en Anglais Américain.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Projets Transversaux
Projets
Publications
Télécharger-
2021Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts., Microb Genom 2021 Feb; (): .
-
2020Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes., Proc. Natl. Acad. Sci. U.S.A. 2020 Aug; 117(34): 20848-20859.
-
2020Phthiocerol Dimycocerosates From Mycobacterium tuberculosis Increase the Membrane Activity of Bacterial Effectors and Host Receptors., Front Cell Infect Microbiol 2020 ; 10(): 420.
-
2020The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection, Elife 2020 May;9.
-
2020Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential, EBioMedicine 2020 Apr;55:102761.
-
2020A systematic approach to simultaneously evaluate safety, immunogenicity, and efficacy of novel tuberculosis vaccination strategies, Sci Adv 2020 03;6(10):eaaz1767.
-
2020Discovery of a novel dehydratase of the fatty acid synthase type II critical for ketomycolic acid biosynthesis and virulence of Mycobacterium tuberculosis, Sci Rep 2020 Feb;10(1):2112.
-
2020TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages, Nat Commun 2020 Feb;11(1):684.
-
2019Mycobacterial virulence: impact on immunogenicity and vaccine research, F1000Res 2019;8.
-
2019Mycobacterium abscessus virulence traits unraveled by transcriptomic profiling in amoeba and macrophages, PLoS Pathog. 2019 Nov;15(11):e1008069.
-
+Voir la liste complète de publications